On 4 June 2021, Swissmedic, Switzerland’s drug approval authority, announced it was extending authorisation of the Pfizer/BioNTech vaccine to 12-15 year olds. © Irina Zharkova | Dreamstime.com The vaccine, also known under the brand name Comirnaty®, has had temporary ordinary authorisation for use in Switzerland on people aged 16 or over since 19 December 2020. Swissmedic started looking at approving the vaccine for use on younger people on 7 May 2021 and reviewed...
Read More »